đź’ŠWill INS018_055 be FDA-approved by 2030?
Mini
3
Ṁ482030
48%
chance
1D
1W
1M
ALL
Insilico Medicine's AI-designed drug for idiopathic pulmonary fibrosis, INS018_055, has entered Phase II clinical trials. Will it become (one of) the first AI-designed drugs to get FDA approval?
Get Ṁ600 play money
Related questions
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
60% chance
Will a drug to be used by most healthy adults be approved by 2043 year end?
60% chance
Will a drug that didn't go through human clinical trials be approved by 2034?
28% chance
The FDA will approve a drug for the treatment of senescence (aging) before the end of the decade (before 2030)
24% chance
Will an AI-designed drug get FDA approval by the end of 2025?
33% chance
Will FDA approve an “AI doctor” for primary care before 2030?
27% chance
Will MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
25% chance
Will there be an FDA-approved age reversal treatment based on partial cell reprogramming by 2030?
34% chance
Will there be an FDA approved cure for Parkinson's Disease by EOY 2032?
50% chance